Navigating The Depths Of Preclinical Oncology To Guide Your Cancer Drug Discovery
Are you looking for a reliable partner to run preclinical oncology studies? Look no further than TD2. Our team of experienced researchers has extensive knowledge in solid and hematologic tumors, immuno-oncology, and adoptive cell therapy. We provide a consultative approach to ensure the best results and continuity with your future clinical and regulatory strategy. With over 600 first-in-human studies under our belt, we have the specialized oncology knowledge to design and execute your preclinical program to support your clinical and regulatory goals. Trust TD2 for optimal study design and rapid study initiation.
Not only can we execute your preclinical studies, but we provide a consultative approach to ensure best results and continuity with a clinical and regulatory strategy. Our team has been involved in 600+ first in human studies. We have the specialized oncology knowledge to design and execute your preclinical program in support of your clinical and regulatory goals.
Comprehensive preclinical services.
Personalized, Expert Support
- 300+ established mouse models
- Adoptive cell therapy models
- VK*Myc mouse
- Glioblastoma PDX
- Humanized mouse models
- 400+ cancer cell lines
- Precision dosing – Tecan D300 digital dispenser
- Combination interactions with immune effector cells
- Synergy studies
- Non-GLP safety and tolerability
- Bioanalytical and DMPK capabilities
- Biomarker screening
- Optical imaging